TARA > School of Medicine > Pharmacology & Therapeutics >
Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Alzheimer's disease brain-derived amyloid-ß-mediated inhibition of LTP In Vivo is prevented by immunotargeting cellular prion protein
Interaction between prion protein and toxic amyloid ß assemblies can be therapeutically targeted at multiple sites.
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity
